Earnings per share for the last twelve months: IDEXX Laboratories (IDXX)

Public company logo of IDEXX Laboratories (IDXX)

IDEXX Laboratories, Inc. (IDXX) creates clinic dependency on its analyzers, ensuring a steady profit stream from the sale of consumables. The rolling 12-month earnings per share trend on GURU.Markets highlights a trajectory where 14.80 serves as the target level. A "razor-and-blade" model integrated with cloud software guarantees expansion, while a closed ecosystem eliminates price competition, cementing absolute market control.

IDXX (IDEXX Laboratories, Inc.) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/16/2026

Analytical breakdowns for IDEXX Laboratories, Inc. (IDXX)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:IDEXX Corp (IDXX)
Flagship merchandise of IDEXX Corp

Net income per share over 12 months measures the equity efficiency of the business by distributing the aggregate financial result across all securities to assess the real return on capital. For IDEXX Laboratories, Inc. (IDXX) and its "razor-and-blade" model, the trailing 12-month net income per share reflects the conversion of steady demand for consumable tests into profit, allowing investors to promptly identify fundamental risks.